Andriole Michael T. - 07 Jan 2025 Form 4 Insider Report for CHIMERIX INC

Role: PRESIDENT AND CEO, Director
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 07 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 10 Jan 2025, 14:57:37 UTC
Previous filing: 09 Aug 2024
Next filing: 31 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Award	$0	+150,000	+32%	$0.000000	619,323	07 Jan 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Stock Option (Right to Buy)	Award	$0	+900,000		$0.000000	900,000	07 Jan 2025	Common Stock	900,000	$3.66	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 37,500 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 37,500 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 37,500 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 37,500 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2	Includes 6,870 shares acquired under the Issuer's Employee Stock Purchase Plan on September 10, 2024.
F3	One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.